Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy

Research output: Contribution to journal › Article › peer-review

Cite this

@article{994d357f31e6445c914448305fa07aa0,

title = "Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy",

author = "Richard Dillon",

year = "2024",

month = jul,

day = "23",

language = "English",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

}